Long Term Bio
Long only, biotech, healthcare, short only

Rxi Pharmaceuticals, Significant Upside Of 300% Is Expected In Coming Months

Rxi Pharmaceuticals (NASDAQ:RXII) is an RNAi biotechnology company that is developing RNAi drug candidates for unmet medical needs. One of its main drugs is known as RXI-109 being developed to treat patients with scars. There is a huge unmet medical need for scars, because the FDA/EMA have no approved drugs...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
You are protected by the Seeking Alpha Money Back Guarantee and will get a prompt refund on the unused portion of your subscription at any time, for any reason.